This event is archived. Final snapshot from when the story concluded. View on Dashboard
Tech medical breakthrough

University of Exeter Finds Diabetes Genes

Analysis based on 8 articles · First reported Apr 09, 2026 · Last updated Apr 13, 2026

Sentiment
60
Attention
4
Articles
8
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

This medical breakthrough by the University of Exeter could lead to new treatments for neonatal diabetes and potentially type 1 diabetes, positively impacting pharmaceutical and biotechnology companies involved in diabetes research and drug development. While not directly affecting stock prices immediately, it signals future opportunities for innovation in the healthcare sector.

Biotechnology Pharmaceuticals Healthcare

Scientists at the University of Exeter, supported by the United Kingdom — National Institute for Health and Care Research, have discovered new genetic causes for neonatal diabetes in babies. The research, led by Elisa De Franco and co-authored by James Russ-Silsby and Matthew Johnson, found that DNA changes in non-coding genes RNU4ATAC and RNU6ATAC are responsible for autoimmune neonatal diabetes in 19 children. This finding is significant because it highlights the importance of non-protein coding genes, which have been historically overlooked, and could lead to new treatments and drug targets for both rare neonatal diabetes and more common type 1 diabetes. The study was published in the American Journal of Human Genetics and will be presented at the European Society of Human Genetics conference.

per
Elisa De Franco, Associate Professor at the University of Exeter Medical School, is the study lead, highlighting the importance of non-protein coding genes in disease.
Importance 80.0 Sentiment 50.0
per
James Russ-Silsby, a co-first author from the University of Exeter, contributed to understanding how DNA changes lead to diabetes through detailed sample analysis.
Importance 70.0 Sentiment 40.0
ngo
The European Society of Human Genetics will host a conference in Sweden where the study's findings will be presented, further disseminating the research.
Importance 40.0 Sentiment 20.0
per
Importance 0 Sentiment 0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.